Eric Legras … THEDOCTORFACTORY … Health & Wellness Strategic Marketing


Popular Stop-Smoking Drugs to Carry Mental Health Risk Warnings by The Doctor Factory

Behavioral Changes, Depressed Mood, Hostility, Suicidal Thoughts Reported With Drugs.

The U.S. Food and Drug Administration said it will immediately require boxed warnings about the risk of serious neuropsychiatric symptoms on the packaging of two popular smoking cessation drugs — varenicline (Chantix) and buproprion (Zyban, Wellbutrin and generics).

Popular Stop-Smoking Drugs to Carry Mental Health Risk Warnings, CHANTIX, FDA

Popular stop-smoking drugs, like Chantix, will soon have boxed warnings indicating mental health risks.

(ABC News Photo Illustration)

Reports of behavioral changes, depressed mood, agitation, hostility and suicidal thoughts and behavior associated with use of the drugs have been submitted to the FDA’s adverse event reporting system.

Throughout the marketing history of the drugs, there have been 98 suicides and 188 attempted suicides in varenicline users and 14 suicides and 17 attempted suicides in buproprion users, the agency reported.


Dejar un comentario so far
Deja un comentario



Responder

Introduce tus datos o haz clic en un icono para iniciar sesión:

Logo de WordPress.com

Estás comentando usando tu cuenta de WordPress.com. Cerrar sesión / Cambiar )

Imagen de Twitter

Estás comentando usando tu cuenta de Twitter. Cerrar sesión / Cambiar )

Foto de Facebook

Estás comentando usando tu cuenta de Facebook. Cerrar sesión / Cambiar )

Google+ photo

Estás comentando usando tu cuenta de Google+. Cerrar sesión / Cambiar )

Conectando a %s



A %d blogueros les gusta esto: